Chris Langmead
Monash University
H-index: 38
Oceania-Australia
Top articles of Chris Langmead
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Characterization of a putative orexin receptor in Ciona intestinalis sheds light on the evolution of the orexin/hypocretin system in chordates | Scientific Reports | Maiju K Rinne Lauri Urvas Ilona Mandrika Dāvids Fridmanis Darren M Riddy | 2024/4/2 |
Sex-Dependent Attentional Impairments in a Subchronic Ketamine Mouse Model for Schizophrenia | Biological Psychiatry Global Open Science | Daisy L Spark Sherie Ma Cameron J Nowell Christopher J Langmead Gregory D Stewart | 2024/1/1 |
Targeting muscarinic receptors for the treatment of alcohol use disorders: Opportunities and hurdles for clinical development | Leigh C Walker Kade L Huckstep Howard C Becker Christopher J Langmead Andrew J Lawrence | 2023/5/1 | |
Does clozapine treat antipsychotic-induced behavioural supersensitivity through glutamate modulation within the striatum? | Molecular Psychiatry | Prashant Tibrewal Pramod C Nair Karen J Gregory Christopher J Langmead Sherry Kit Wa Chan | 2023/5 |
Ligand-directed biased agonism at human histamine H3 receptor isoforms across Gαi/o-and β-arrestin2-mediated pathways | Biochemical Pharmacology | Sabrina N Rahman Faissal Imhaouran Rob Leurs Arthur Christopoulos Céline Valant | 2023/12/28 |
Acetylcholine receptors (muscarinic) in GtoPdb v. 2023.1 | IUPHAR/BPS Guide to Pharmacology CITE | Nigel JM Birdsall Sophie Bradley David A Brown Noel J Buckley RA John Challiss | 2023/4/26 |
Gpr88 Deletion Impacts Motivational Control Without Overt Disruptions to Striatal Dopamine | Biological Psychiatry Global Open Science | Daisy L Spark Michela H Vermeulen Rocío A de la Fuente Gonzalez Cassandra J Hatzipantelis Patricia Rueda | 2023/10/1 |
Structural and Molecular Determinants for Isoform Bias at Human Histamine H3 Receptor Isoforms | ACS Chemical Neuroscience | Sabrina N Rahman Daniel A McNaught-Flores Yara Huppelschoten Daniel da Costa Pereira Arthur Christopoulos | 2023/1/26 |
" We don't want to run before we walk": the attitudes of Australian stakeholders towards using psychedelics for mental health conditions | Public Health Research & Practice | Breanne E Kunstler Liam Smith Christopher J Langmead Denise M Goodwin Breanna Wright | 2023/9/13 |
Molecular insights into orphan G protein‐coupled receptors relevant to schizophrenia | Yao Lu Cassandra J Hatzipantelis Christopher J Langmead Gregory D Stewart | 2023/1/18 | |
Molecular and structural insights into the 5‐HT2C receptor as a therapeutic target for substance use disorders | Maleesha Ubhayarathna Christopher J Langmead Natalie A Diepenhorst Gregory D Stewart | 2023/9/7 | |
Trace Amine-associated receptor 1 (TAAR1): molecular and clinical insights for the treatment of schizophrenia and related comorbidities | ACS Pharmacology & Translational Science | Pramod C Nair Justin M Chalker Ross A McKinnon Christopher J Langmead Karen J Gregory | 2022/2/18 |
Opportunities and challenges for the development of M1 muscarinic receptor positive allosteric modulators in the treatment for neurocognitive deficits | Christopher P Millward Terri S Armstrong Heather Barrington Andrew R Brodbelt Helen Bulbeck | 2022/7/1 | |
M1 muscarinic receptor activation decreases alcohol consumption via a reduction in consummatory behavior | Pharmacology Research & Perspectives | Leigh C Walker Erin J Campbell Kate L Huckstep Nicola A Chen Christopher J Langmead | 2022/2 |
Molecular and structural insights into the serotonin 5-HT2C receptor as a therapeutic target for substance use disorders | Maleesha Ubhayarathna Chris Langmead Natalie Diepenhorst Gregory Stewart | 2022/11/8 | |
Attitudes and beliefs about the medically supervised use of psychedelic medications for the treatment of mental health conditions | Breanne Kunstler Melissa Hatty Anna Genat Liam Smith Denise Goodwin | 2022 | |
Gpr88 deletion impacts motivational control independently of striatal dopamine function | bioRxiv | Daisy L Spark Michela H Vermeulen Patricia Rueda Rocío de la Fuente Gonzalez Tara Sepehrizadeh | 2022/5/20 |
Binding of SEP-363856 within TAAR1 and the 5HT1A receptor: implications for the design of novel antipsychotic drugs | Pramod C Nair John O Miners Ross A McKinnon Christopher J Langmead Karen J Gregory | 2022/1 | |
Beyond antipsychotics: a twenty-first century update for preclinical development of schizophrenia therapeutics | Daisy L Spark Alex Fornito Christopher J Langmead Gregory D Stewart | 2022/4/7 | |
Multipathway In vitro pharmacological characterization of specialized proresolving G protein-coupled receptors | Molecular Pharmacology | Jon Merlin Julia Park Teresa H Vandekolk Stewart A Fabb Jeanne Allinne | 2022/4/1 |
Co-Authors
